Physician profile
Timothy Clinton
NPI 1598175432
$37,119.00
in general payments reported to CMS, 2019-2025
10 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13K · 2024: $10K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $13K · Consulting Fee: $8,020 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,150 · Food and Beverage: $4,540 · Travel and Lodging: $4,236 · Honoraria: $400 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,750.00 |
| Consulting Fee | $8,020.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,150.00 |
| Food and Beverage | $4,540.14 |
| Travel and Lodging | $4,236.02 |
| Honoraria | $400.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,150.13 | 2023-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Medtronic, INC. | $6,057.11 | 2023-2024 | Interstim |
| Olympus Medical Systems Corporation | $1,620.00 | 2023 | Oes Choledochofiberscope |
| Fennec Pharmaceuticals, INC. | $1,278.98 | 2024-2025 | Pedmark, Fyarro |
| Gyrus Acmi, INC. | $600.00 | 2025 | Uretero-Reno Videoscope |
| Edap Technomed INC | $513.00 | 2024 | |
| Becton, Dickinson and Company | $418.92 | 2025 | Arista, Surgiphor |
| Bard Peripheral Vascular, INC. | $400.00 | 2023 | |
| Janssen Biotech, INC. | $62.19 | 2025 | Erleada |
| Astellas Pharma US INC | $18.67 | 2024 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Clinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.